Traditionally used in Western herbal medicine to support migraine prevention

May help reduce the frequency of migraine headaches when used consistently under professional guidance

Provides quantified parthenolide content

Offers a flexible liquid format for individualised practitioner prescribing

May be combined with compatible herbal extracts where professionally appropriate

Research into Feverfew for migraine prevention has produced mixed results, so it should not be presented as a guaranteed migraine treatment. European monograph guidance recognises traditional use for migraine prevention after serious causes have been excluded by a doctor.

Adults receiving practitioner-guided migraine-prevention support

People with an established migraine pattern that has been appropriately assessed

Adults prescribed Feverfew as part of an individualised herbal protocol

Professional herbal compounds supporting recurrent migraine patterns

Customers requiring a concentrated liquid extract rather than tablets or capsules

People whose medicines, bleeding risk, pregnancy status and allergy history have been professionally reviewed

This product is not intended for immediate relief of an acute migraine or for the unsupervised management of new, severe, worsening or unusual headaches.

Common name: Feverfew

Botanical name: Tanacetum parthenium

Plant part used: Leaf

Plant family: Asteraceae, formerly known as Compositae

Extract ratio: 1:5

Active marker compound: Not less than 0.3 mg/mL parthenolide

Ethanol content: 60% v/v

Format: Single-herb practitioner liquid extract

Bottle size: 500 mL

Feverfew (Tanacetum parthenium) leaf 1:5 liquid extract.

Contains not less than 0.3 mg/mL of parthenolide.

Contains ethanol 60% v/v.

Adults: Take 7–14 mL per week, or as directed by a qualified healthcare practitioner.

This is a weekly dosage range and must not be interpreted as 7–14 mL per day.

Confirm the prescribed amount against the current product label before use.

Shake well before use.

Measure the prescribed amount carefully.

Take only according to the current product label or your healthcare practitioner’s directions.

The prescribed amount may be diluted in a small quantity of water immediately before taking.

Feverfew is generally used consistently within a practitioner-directed migraine-prevention plan rather than taken only after migraine pain begins.

Do not exceed the recommended or professionally prescribed amount.

Do not increase the dosage because a migraine remains present.

Do not replace prescribed acute or preventive migraine medication without consulting the prescribing healthcare professional.

No added gluten or dairy.

Vegan-friendly.

Do not use if you have a known allergy to Feverfew, parthenolide or another plant in the Asteraceae family.

Related plants may include ragweed, daisies, chrysanthemums and marigolds.

Stop use and seek urgent medical attention if facial swelling, throat tightness, breathing difficulty, widespread hives or another serious allergic reaction develops.

Feverfew is contraindicated in people allergic to the herb or related Asteraceae plants.

For practitioner dispensing and professionally guided use.

Always read the label and follow the directions for use.

Do not use during pregnancy unless specifically directed after professional assessment and the current Australian label has been reviewed.

Feverfew may influence uterine contractions, and established monograph guidance does not recommend medicinal use during pregnancy because adequate safety has not been established.

Use during breastfeeding only when specifically directed by a qualified healthcare practitioner. Reliable safety information during breastfeeding is limited.

Do not use if you have a known sensitivity to Feverfew, parthenolide or another Asteraceae plant.

Consult your healthcare practitioner before use if you have a bleeding disorder, bruise easily or experience unusually heavy menstrual bleeding.

Consult your healthcare practitioner before use if you take warfarin, aspirin, clopidogrel, anticoagulant medicines, antiplatelet medicines, anti-inflammatory medicines or another product that may affect blood clotting.

Feverfew may slow blood clotting and may interact with medicines, including some medicines used for migraine.

Consult your healthcare practitioner before combining Feverfew with triptans, migraine-prevention medicines or frequent pain-relief medication.

Discontinue use before surgery, general anaesthesia or an invasive dental procedure. The current GhamaHealth page specifies at least seven days before general anaesthesia, while broader safety guidance recommends stopping Feverfew two weeks before scheduled surgery. Follow the longer period where advised by your treating practitioner.

The page provides an adult dosage only. Do not give this 60% ethanol practitioner extract to children or adolescents unless it has been individually prescribed.

Possible adverse effects include nausea, bloating, digestive discomfort, rash or oral irritation.

Do not use this product as a substitute for migraine diagnosis, neurological assessment or prescribed treatment.

Seek medical review if headaches become more frequent, severe or different from the established pattern.

Call triple zero or seek urgent hospital care for a sudden severe headache or a headache accompanied by confusion, neck stiffness, visual changes, loss of balance, seizure, fever or unexplained vomiting.

Stop use and seek professional advice if symptoms worsen or an unexpected reaction occurs.

Contains 60% ethanol.

Keep out of reach of children.

Store below 25°C in a cool, dry place away from direct sunlight and excessive heat.

Keep the bottle tightly closed when not in use.

Store away from flames, sparks and ignition sources due to the ethanol content.

Follow any additional storage instructions printed on the current product label.